If you require further searching capabilities for announcements please email: data@nzx.com

TruScreen Completes Successful Capital Raising

05/10/2018, 08:31 NZDT, OFFER

Company Announcement 5 October 2018 TRUSCREEN COMPLETES SUCCESSFUL CAPITAL RAISING Cervical cancer technology company, TruScreen Limited (TRU: NZAX) advises that it has successfully completed its Share Purchase Plan (SPP) offer. Chairman of TruScreen, Mr Tony Ho, said: "TruScreen has several immediate commercial opportunities and the capital raised will enable us to maximise those opportunities. We are very pleased with the support we have received from our shareholders, reflecting their confidence in our strategy." TruScreen will issue 7,411,964 ordinary shares at NZD 21 cents each, totalling $1,556,500 in new capital. The SPP was the second stage of TruScreen's equity capital raising programme and followed the successful $1,500,000 placement to institutional and professional investors which was completed on 31 August 2018. Funds will be used to: o Build on and expand commercial growth in China, Africa, India and Latin America; o Fund clinical and familiarisation trials as required for further product enhancement and acceptance in government programs; o Expand manufacturing and supply capabilities; o Provide additional working capital; and o Continued product development. The SPP closed on 3 October 2018 and shares will be allotted on 9 October 2018. ENDS For more information visit www.truscreen.com or contact Martin Dillon, TruScreen Chief Executive Officer, email: martindillon@truscreen.com. About TruScreen: TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection. For further news update vist Truscreen Limited's website at www.truscreen.com End CA:00324896 For:TRU Type:OFFER Time:2018-10-05 08:31:04

Downloads

Historical Announcement's attachments older than 7 years are not available on this platform